Köklü Seyfettin, Oztürk Mehmet Akif, Balci Mustafa, Yüksel Osman, Ertenli Ihsan, Kiraz Sedat
Department of Gastroenterology, Türkiye Yüksek Ihtisas Hospital, Ankara, Turkey.
Joint Bone Spine. 2005 Jan;72(1):38-40. doi: 10.1016/j.jbspin.2004.03.011.
To evaluate the levels of endogenous interferon-gamma (IFN-gamma) in patients with familial Mediterranean fever (FMF).
Plasma levels of IFN-gamma were assayed in 29 FMF patients in attack-free period (mean age: 32, min-max: 17-48; male/female: 10/19), 18 FMF patients with acute FMF attack (mean age: 32, min-max: 19-50; male/female: 8/10), and 19 healthy controls (mean age: 31.94 +/- 1.50, min-max: 23-42; male/female: 11/8). IFN-gamma levels were also compared among colchicine treated and untreated groups.
Median plasma IFN-gamma levels were significantly higher in patients both with and without FMF attack than the control group (P < 0.05). Moreover, plasma IFN-gamma levels were higher in patients with acute FMF attack compared to patients in attack-free periods (P < 0.05). Plasma levels of IFN-gamma were comparable in colchicine treated and untreated groups.
Our results suggest that IFN-gamma may contribute to the inflammatory cascade of FMF.
评估家族性地中海热(FMF)患者体内内源性干扰素-γ(IFN-γ)的水平。
检测29例处于无发作期的FMF患者(平均年龄:32岁,最小-最大年龄:17 - 48岁;男/女:10/19)、18例急性发作期的FMF患者(平均年龄:32岁,最小-最大年龄:19 - 50岁;男/女:8/10)以及19名健康对照者(平均年龄:31.94 ± 1.50岁,最小-最大年龄:23 - 42岁;男/女:11/8)的血浆IFN-γ水平。还比较了秋水仙碱治疗组和未治疗组的IFN-γ水平。
无论有无FMF发作,患者的血浆IFN-γ中位数水平均显著高于对照组(P < 0.05)。此外,急性发作期的FMF患者血浆IFN-γ水平高于无发作期的患者(P < 0.05)。秋水仙碱治疗组和未治疗组的血浆IFN-γ水平相当。
我们的结果表明,IFN-γ可能参与了FMF的炎症级联反应。